beyond pink team
  • Home
  • About Us
    • Who We Are
    • Our Board
    • Annual Report
    • Contact Us
  • Support
    • Physical
    • Emotional
    • Community
    • Financial
    • Caregiver
    • Online
  • Education
    • Newsletter
    • Ignite the Cancer Conversation
    • Quality Care
    • Resources
    • Request Speaker
    • The Cancer Journey
  • Advocacy
    • What is Advocacy
    • National Breast Cancer Coalition
    • Iowa Stop Breast Cancer
    • Research
    • Influencing Policy
    • Access to Care
  • Join Us
    • Be an Advocate
    • Volunteer
    • Events >
      • 16th Annual Pink Ribbon Run
    • Membership
    • Donate to BPT
    • Follow Us
 If you are Breast Cancer Survivor and  you would like to contribute your story to our Newsletter, 
​please send us a message here.
DOWNLOAD Current NewsletteR

Categories

All
Advocacy
Bone Health
Breast Density
Breast Disease
Caregivers
COVID 19
COVID-19
Emotional Support
Environment
Exercise
Fatigue
Financial
Gender
Genetic Testing
Grief
High Risk
Hormone Replacement Therapy
Ignite
Implants
Intimacy After Cancer
LGBTQ
Lymphedema
Mammography
Meditation
Men
Mental Health
Metastasis
MRI
NBCC
Nutrition
Obesity
Pain
Pregnancy
Prevention
Radiation
Reconstruction
Reduce Risk
Rehabilitation
Screening
Sex
Side Effects
Support Groups
Surgery
Survivor
Survivorship
Treatment
Vaccine
Yoga
Young Women

Archives

January 2023
October 2022
July 2022
April 2022
January 2022
October 2021
July 2021
April 2021
January 2021
October 2020
July 2020
April 2020
January 2020
October 2019
July 2019
April 2019
January 2019
October 2018
July 2018
April 2018
January 2018
October 2017
July 2017
April 2017
January 2017
October 2016
July 2016
April 2016
January 2016
October 2015
July 2015
April 2015
January 2015
October 2014
July 2014
April 2014
January 2014
October 2013
July 2013
April 2013
January 2013
October 2012
July 2012
April 2012
January 2012
October 2011
July 2011
April 2011
January 2011
October 2010
July 2010
April 2010
January 2010
October 2009
July 2009
April 2009
January 2009
October 2008
July 2008
April 2008
January 2008
October 2007
July 2007
April 2007
January 2007
October 2006
July 2006
April 2006
January 2006
October 2005
July 2005
April 2005
January 2005
October 2004
July 2004
April 2004
January 2004

GENETIC TESTING FOR BREAST CANCER

4/1/2007

0 Comments

 
Picture
By Joginder Singh, M.D.

Breast Cancer is a common cancer. One in 9 women will have breast cancer in their lifetime. Most women are scared of the hereditary nature of breast cancer. They would like to know the chances of breast cancer in their siblings and children. It should be noted that most breast cancers are sporadic and no hereditary cause is found. Only 7-10% of breast cancers are due to hereditary factors. Major causes of hereditary breast cancer are due to alterations of genes BRCA1 and BRCA2.

What are BRCA1 and BRCA2 mutation?
Every human cell (except red blood cells) has a nucleus, which has 23 pairs of chromosomes. Chromosomes contain DNA (Deoxyribonucleic acid). DNA exists as two long paired strands spiraled into a double helix. Each strand is made up of millions of chemical building blocks called bases. There are only four different chemical bases in DNA (Adenine, Thymine, Cytosine, Guanine) but they can be arranged and rearranged in countless ways. The order in which bases occur determine the message to be conveyed much as specific letters of the alphabet combine to form words and sentences. Cell function is determined by protein and structure of proteins and function depends on structure of DNA. If there is mutation or change in normal base pair sequence in DNA proteins formed may not function or function differently. It should be noted, that some mutations are silent. Like the words GRAY and GREY are different but mean the same. However, if you change GRAY and GREY to GRZY, it does not mean anything and the protein may not function. BRCA is located on chromosome 17 and BRCA2 is located on chromosome 13. 500 different mutations have been found in BRCA1 and 300 in BRCA2, however, many mutations are silent and some are of unknown significance.

Who should be tested?
​Because these tests have implications not only on the individual being tested but also on the whole family, the individual being tested should be given detailed information about the risks and benefits of testing.

Features that increase likelihood of having BRCA mutation are:
1. Multiple cases of early onset breast cancer.
2. History of ovarian cancer in same family.
3. Breast and ovarian cancer in
4. same woman.
5. History of bilateral breast cancer.
6. Ashkanezi Jewish heritage since there is a higher incidence of a particular mutation in those families.
7. Male breast cancer.

Pattern of Inheritance
These mutations are transmitted by autosomal dominant inheritance, which means that they are transmitted equally by males and females. 50% of offspring’s of affected persons will carry the mutation; it does not depend on sex. It is a very common misunderstanding among patients that inheritance only comes from mother, whereas fathers transmit genes equally.

What can be done if BRCA mutation is found?
1. Monthly breast examinations starting at the age of 18.
2. Clinical exam every 6 months beginning at age 25.
3. Mammograms and MRI of breast beginning at age 25 or individualized depending on the age of the youngest relative with cancer. MRI is more sensitive than mammograms in mutation carriers.
4. Prophylactic mastectomy decreases risk of breast cancer by more than 90%.
5. Prophylactic oophorectomy (removal of ovaries) after childbearing age decreases risk of both breast and ovary cancer.
6. Tamoxifen or Raloxifene considered chemoprevention could be considered.

Benefits of gene testing:
1. Gives relief when tests are negative.
2. Intervention can be done to prevent cancer if results are positive.
3. Informed decisions and fewer check ups.

Limitations of testing:
1. Psychological distress if positive.
2. Some mutations may never lead to cancer, but give distress because we may never know the meaning of such variation such as GRAY and GREY words.
3. Insurance issues even though there are laws against insurance discrimination.

The decision to undergo testing should be personal and voluntary. These tests should not be done to please relatives, friends, children, siblings, or health care providers.


​


​

​ 

Read Full Newsletter
0 Comments



Leave a Reply.

CONTACT US

Beyond Pink TEAM
c/o Jeanne Olson, Treasurer
1407 Asbury Lane
Waterloo, IA 50701
​beyondpinkteam@gmail.com
(319) 239-3706
©2020 Beyond Pink TEAM
  • Home
  • About Us
    • Who We Are
    • Our Board
    • Annual Report
    • Contact Us
  • Support
    • Physical
    • Emotional
    • Community
    • Financial
    • Caregiver
    • Online
  • Education
    • Newsletter
    • Ignite the Cancer Conversation
    • Quality Care
    • Resources
    • Request Speaker
    • The Cancer Journey
  • Advocacy
    • What is Advocacy
    • National Breast Cancer Coalition
    • Iowa Stop Breast Cancer
    • Research
    • Influencing Policy
    • Access to Care
  • Join Us
    • Be an Advocate
    • Volunteer
    • Events >
      • 16th Annual Pink Ribbon Run
    • Membership
    • Donate to BPT
    • Follow Us